MTP-493G>T polymorphism and susceptibility to nonalcoholic fatty liver disease: A meta-analysis

DNA and Cell Biology

Volumn 33, Issue 6, 2014, Pages 361-369

  Zheng, Wei ^a   Wang, Lu ^a   Su, Xiao ^a   Hu, Xiao Fang ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CINAHL; COCHRANE LIBRARY; DATA BASE; DNA SEQUENCE; ETHNICITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; FATTY LIVER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84901714613     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2238     Document Type: Article

References (36)

1. Adams, L.A., Waters, O.R., Knuiman, M.W., Elliott, R.R., and Olynyk, J.K. (2009). NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An elevenyear follow-up study. Am J Gastroenterol 104, 861-867
2. Carulli, L., Canedi, I., Rondinella, S., Lombardini, S., Ganazzi, D., Fargion, S., et al. (2009). Genetic polymorphisms in nonalcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig Liver Dis 41, 823-828
3. Di Filippo, M., Crehalet, H., Samson-Bouma, M.E., Bonnet, V., Aggerbeck, L.P., Rabes, J.P., et al. (2012). Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia. J Lipid Res 53, 548-555
4. Dowman, J.K., Tomlinson, J.W., and Newsome, P.N. 2010 Pathogenesis of non-alcoholic fatty liver disease. QJM 103, 71-83
5. Dupont, W.D., and Plummer, W.D., Jr. (1990). Power and sample size calculations. A review and computer program. Control Clin Trials 11, 116-128
6. Duvnjak, M., Barsic, N., Tomasic, V., and Lerotic, I. (2009). Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis and disease progression. World J Gastroenterol 15, 6023-6027
7. El-Koofy, N.M., El-Karaksy, H.M., Mandour, I.M., Anwar, G.M., El-Raziky, M.S., and El-Hennawy, A.M. (2011). Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. Saudi J Gastroenterol 17, 265-270
8. Fan, J.G., and Farrell, G.C. (2009). Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol 50, 204-210
9. Fon Tacer, K., and Rozman, D. (2011). Nonalcoholic Fatty liver disease: Focus on lipoprotein and lipid deregulation. J Lipids 2011, 783976
10. Gambino, R., Cassader, M., Pagano, G., Durazzo, M., and Musso, G (2007). Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45, 1097-1107
11. Hashemi, M., Hoseini, H., Yaghmaei, P., Moazeni-Roodi, A., Bahari, A., Hashemzehi, N., et al. (2011). Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell Biol 30, 569-575
12. Hussain, M.M., Rava, P., Walsh, M., Rana, M., and Iqbal, J. (2012). Multiple functions of microsomal triglyceride transfer protein. Nutr Metab (Lond) 9, 14
13. Jackson, D., White, I.R., and Riley, R.D. (2012). Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31, 3805-3820
14. Liu, Q., Bengmark, S., and Qu, S. (2010). The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 9, 42
15. Malaguarnera, M., Di Rosa, M., Nicoletti, F., and Malaguarnera, L. (2009). Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) 87, 679-695
16. Mirandola, S., Osterreicher, C.H., Marcolongo, M., Datz, C., Aigner, E., Schlabrakowski, A., et al. (2009). Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver Int 29, 557-565
17. Musso, G., Gambino, R., and Cassader, M. (2010). Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. J Nutr Biochem 21, 834-840
18. Musso, G., Gambino, R., and Cassader, M. (2009). Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48, 1-26
19. Musso, G., Gambino, R., De Michieli, F., Biroli, G., Premoli, A., Pagano, G., et al. (2007). Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: Possible role of vitamin A intake. Am J Clin Nutr 86, 661-671. (Pubitemid 47435833)
20. Namikawa, C., Shu-Ping, Z., Vyselaar, J.R., Nozaki, Y., Nemoto, Y., Ono, M., et al. (2004). Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40, 781-786. (Pubitemid 38507358)
21. Oliveira, C.P., Stefano, J.T., Cavaleiro, A.M., Zanella Fortes, M.A., Vieira, S.M., Rodrigues Lima, V.M., et al. (2010). Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 25, 357-361
22. Patton, H.M., Yates, K., Unalp-Arida, A., Behling, C.A., Huang, T.T., Rosenthal, P., et al. (2010). Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol 105, 2093-2102
23. Pereira, I.V., Stefano, J.T., and Oliveira, C.P. (2011). Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 5, 245-251
24. Peters, J.L., Sutton, A.J., Jones, D.R., Abrams, K.R., and Rushton, L. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295, 676-680
25. Petit, J.M., Masson, D., Minello, A., Duvillard, L., Galland, F., Verges, B., et al. (2006). Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients. Mol Genet Metab 88, 196-198
26. Postic, C., and Girard, J. (2008). The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34, 643-648
27. Shimabukuro, M., Higa, M., Yamakawa, K., Masuzaki, H., and Sata, M. (2013). Miglitol, alpha-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: A randomized comparable study. Int J Cardiol 167, 2108-2113
28. Siqueira, E.R., Oliveira, C.P., Correa-Giannella, M.L., Stefano, J.T., Cavaleiro, A.M., Fortes, M.A., et al. (2012). MTP - 493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients. Braz J Med Biol Res 45, 72-77
29. Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603-605
30. Sun, Y., Lian, Z., Jiang, C., Wang, Y., and Zhu, H. (2012). Beneficial metabolic effects of 2¢, 3¢, 5¢-tri-acetyl-N6- (3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters. PLoS One 7, e32115
31. Vanni, E., Bugianesi, E., Kotronen, A., De Minicis, S., Yki- Jarvinen, H., and Svegliati-Baroni, G
32. Wilfred De Alwis, N.M., and Day, C.P. (2007). Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 27, 44-54
33. Wong, V.W., Wong, G.L., Yip, G.W., Lo, A.O., Limquiaco, J., Chu, W.C., et al. (2011). Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60, 1721-1727
34. Yoon, D., Lee, S.H., Park, H.S., Lee, J.H., Park, J.S., Cho, K.H., et al. (2005). Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease. J Korean Med Sci 20, 421-426. (Pubitemid 40908921)
35. Zampino, R., Ingrosso, D., Durante-Mangoni, E., Capasso, R., Tripodi, M.F., Restivo, L., et al. (2008). Microsomal triglyceride transfer protein (MTP) - 493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J Viral Hepat 15, 740-746
36. Zintzaras, E., and Ioannidis, J.P. (2005). HEGESMA: Genome search meta-analysis and heterogeneity testing. Bioinformatics 21, 3672-3673.